FDA Drug Approval Database

FDA approves Eli Lilly weight-loss pill Foundayo

Digest more

· 23m

FDA Approves Eli Lilly’s GLP-1 Pill

The US Food and Drug Administration on Wednesday approved a new obesity pill called Foundayo.

· 3h · on MSN

FDA approves lower-cost daily weight loss pill from Eli Lilly

· 8h

FDA Grants Speedy Approval to Eli Lilly's Weight-Loss Pill for Obesity

· 9h

Another GLP-1 weight loss pill gets FDA approval, and it has fewer restrictions on how it’s used

The US Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a rapidly growing arsenal of obesity therapies.

· 9h

Lilly’s Obesity Pill Gets US Approval in Challenge to Novo

Domain-b · 15h

India tightens oversight on GLP-1 drugs, warns against misuse for weight loss

The Navhind Times · 5h

Govt: Surveillance to continue on GLP-1 weight loss drugs

The drugs carry a wide range of side effects – from common symptoms like nausea and vomiting to severe complications including pancreatitis, kidney injury, and bowel obstruction.

· 6h

VIEW Lilly gets FDA nod for oral obesity pill, analysts see strong uptake potential

· 8h

Race to launch weight-loss pill heats up as Lilly wins US approval

4hon MSN

US FDA clarifies policies on compounding of GLP-1 medicines

April 1 (Reuters) - The U.S. Food and Drug Administration on Wednesday clarified its policies on compounded versions of popular GLP-1 drugs, signaling tighter limits on their production as national supply conditions improve.

7don MSN

Denali gains on FDA approval of lead asset

Denali Therapeutics (DNLI) added ~9% in the premarket on Wednesday after the U.S. Food and Drug Administration (FDA) approved its lead candidate, tividenofusp alfa, as a treatment for Hunter syndrome,

Applied Clinical Trials Online

Four FDA Actions Reshaping Drug Development in 2026

Early 2026 has brought a series of consequential regulatory moves from the FDA, each reflecting a common thread: the agency is recalibrating its evidentiary standards to align wit

Yahoo

Drugs are winning approval even when trials fail — but should they?

This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. When Sarepta Therapeutics revealed this month that a confirmatory trial for two of its marketed Duchenne muscular ...

FiercePharma

2025 approvals: Biopharma delivered 55 new drugs, biologics

While it would be presumptuous to base conclusions solely on the number of drugs the FDA approved in 2025, it is noteworthy that FDA nods of new treatments fell short of previous years, though a surge of green lights in December helped make the final ...